Analyst Recommendations

Stephens analyst issues EQUAL-WEIGHT recommendation for KMX on April 9, 2024 11:13AM ET. The previous analyst recommendation was Equal-Weight.KMX was trading at $83.01 at issue of the analyst...

April 9, 2024   KMX -1.03%

Morgan Stanley analyst issues OVERWEIGHT recommendation for LVS on April 9, 2024 11:42AM ET. The previous analyst recommendation was Overweight.LVS was trading at $52.22 at issue of the...

April 9, 2024   LVS -0.34%

BMO Capital analyst issues OUTPERFORM recommendation for TGB on April 9, 2024 11:00AM ET. The previous analyst recommendation was Outperform.TGB was trading at $2.52 at issue of the...

April 9, 2024   TGB 2.84%

Needham analyst issues BUY recommendation for RXRX on April 9, 2024 10:00AM ET. The previous analyst recommendation was Buy.RXRX was trading at $9.165 at issue of the analyst...

April 9, 2024   RXRX -4.39%

RBC Capital analyst issues UNDERPERFORM recommendation for PCRX on April 9, 2024 10:00AM ET. The previous analyst recommendation was Underperform.PCRX was trading at $28.44 at issue of the...

April 9, 2024   PCRX 0.68%

Wedbush analyst issues BUY recommendation for PCRX on April 9, 2024 10:00AM ET. The previous analyst recommendation was Buy.PCRX was trading at $28.44 at issue of the analyst...

April 9, 2024   PCRX 0.68%

Susquehanna analyst issues BUY recommendation for BABA on April 9, 2024 10:01AM ET. The previous analyst recommendation was Buy.BABA was trading at $72.7012 at issue of the analyst...

April 9, 2024   BABA -3.78%

Piper Sandler analyst issues BUY recommendation for CUE on April 9, 2024 10:01AM ET. The previous analyst recommendation was Buy.CUE was trading at $1.9 at issue of the...

April 9, 2024   CUE 1.61%

Oppenheimer analyst issues UNDERPERFORM recommendation for CUE on April 9, 2024 10:01AM ET. The previous analyst recommendation was Underperform.CUE was trading at $1.9 at issue of the analyst...

April 9, 2024   CUE 1.61%

Wells Fargo analyst issues STRONG BUY recommendation for PR on April 9, 2024 10:01AM ET. The previous analyst recommendation was Strong Buy.PR was trading at $18.15 at issue...

April 9, 2024   PR 2.40%